Personalized Health and Related Technologies (PHRT) is a strategic focus area of the ETH Domain; the latter embracing key research institutions like ETHZ, EPFL, PSI, EMPA, Eawag and WSL. PHRT’s goals include improving the quality of Personalized Health and Precision Medicine by providing a choice of individual therapeutic strategies for patients.
Through calls for proposals, PHRT funds interdisciplinary projects in education (doctoral and postdoc level), technology translation and research in order to foster the development of Precision Medicine and health research. PHRT connects hospitals and the institutions that make up the ETH Domain so that they can share and use health data across Switzerland.
In Switzerland, a number of national and international programs have committed themselves to the goal of personalized medicine. These include the strategic focus area PHRT of the ETH Domain and the SPHN initiative (Swiss Personalized Health Network) of the Swiss Academy of Medical Sciences. The two programs complement each other and coordinate their activities in order to promote Personalized Health and Personalized Medicine, in Switzerland.
4 June, 2021, Geneva
Swiss Genomics Forum 2021
The SGF2020 at Campus Biotech in Geneva - a full-day event - will bring together researchers, clinicians, patient communities, and other stakeholder groups to meet and discuss the future of genomics.
13 – 15 September 2021, Basel
[BC]2 Basel Computational Biology Conference
The [BC]2 Basel Computational Biology Conference is Switzerland's main event in the domain of Computational Biology and one of the major events of its kind in Europe.
29 November 2021, Basel
DQBM Founding Symposium: Frontiers in Biomedical Research
The 2020 DQBM Founding Symposium is an international event, open to all students and scientists in Switzerland and abroad with -200 expected participants. By providing an exciting forum to disseminate the latest developments in Precision Medicine, this symposium will elucidate frontiers in this research field and intends to strengthen scientific exchange within the Swiss Precision Medicine community.
ETH Board approves second phase of PHRT for 2021-2024
The ETH Board has approved a second phase of Personalized Health and Related Technologies (PHRT), one of the ETH Domain’s four strategic focus areas. PHRT will launch its next call for proposals at the beginning of 2021.
3rd call for proposals: approved projects
With its 3rd call for proposals, PHRT invited clinical scientists, who have access to an extensive sample cohort, to create an inter-institutional, interdisciplinary consortium to formulate a well-defined clinical question to request funding to generate matched genomic, transcriptomic and proteomic data by the two PHRT platforms. Based on the suggestion of the Review Panel, the Executive Committee approved 3 of 8 projects, which will be supported with CHF 1,5 million.
New chairperson for the Executive Committee
Prof. Dr. Ruedi Aebersold resigned as the chairperson of the PHRT Executive Committee by May 22, 2019 and is succeeded by Prof. Dr. Bernd Wollscheid.